A new unique analysis Interleukin-6 is available for patients of the OLYMP CDL.

Interleukin-6 (IL-6) is an active mediator of inflammation, i.e. an endogenous substance that ensures the pathophysiological processes of the inflammatory response. In this regard, the test is informative for patients with many inflammatory diseases. The test has become especially widespread in rheumatology in the treatment of rheumatoid arthritis, which is associated not only with the active role of IL-6 in autoimmune inflammation, but also with the fact that a number of drugs are aimed specifically at reducing the concentration of interleukin-6.

IL-6:

• Correlates with the severity of the inflammatory process;
• Serves as a target for immunosuppressive therapy;
• Allows monitoring the dynamics of the course and effectiveness of treatment of oncological and inflammatory diseases of any etiology;
• Prognosis of recurrence of chronic inflammatory diseases.

Details in the contact center: 59-79-59 (259-79-59 for Almaty)